Supporting NHS England’s consultation on low-value medicines
Home » Case studies » Supporting NHS England’s consultation on low-value medicines
In 2017, NHS England sought public and patient input on proposals to limit the prescribing of 18 products considered low-value for routine NHS primary care prescriptions. Our communications, engagement, and medicines management teams collaborated to lead this consultation and analyse the findings.
With 5,544 survey responses and 195 written submissions, alongside webinars, public events, and stakeholder meetings, we compiled a comprehensive report. Our analysis played a key role in NHS England’s decision to stop prescribing certain ineffective treatments, while altering others based on stakeholder input, ultimately benefiting patients and reducing costs.
Supporting ICSs with approaches to design and deliver effective communication, engagement and behavioural insights as a key enabler for system change and…
Acting as an independent and trusted partner within the system to facilitate working across stakeholders and integrate elements of the provider system…
Digitising care and partnering with systems for the transformation of digitally enabled service delivery (and other supporting processes) across vision, planning and…
Supporting systems to build a sustainable and integrated workforce, transforming systems, organisations and the workforce experience to improve resilience.
Providing end-to-end funded care services, including patients as active partners in identifying their healthcare needs and then commissioning care to meet these.…
Applying intelligence-led understanding of the health of the population to support the redesign of care and improve patient and financial outcomes across…
Supporting providers to work together at a place and neighbourhood level to manage common resources, integrate community teams, improve health and reduce…